Clinical Practice
Geriatric Psychopharmacology for PMHNPs: Safe Prescribing for Older Adults
Older adults are the fastest-growing population in psychiatric practice, and standard adult prescribing approaches can be dangerous in this group.
Tagged
Medication Management
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Clinical Practice
Pediatric Psychopharmacology for PMHNPs: Safe Prescribing for Children and Adolescents
Prescribing psychiatric medications for children and adolescents requires different pharmacological considerations, monitoring protocols, and risk-benefit...
Clinical Practice
PTSD Treatment Updates for PMHNPs: Pharmacotherapy Beyond Sertraline in 2026
PTSD pharmacotherapy has evolved well beyond first-line SSRIs. This guide covers the updated evidence for prazosin, second-generation antipsychotic...
Clinical Practice
Anxiety Treatment Beyond SSRIs: A PMHNP Prescribing Guide for 2026
SSRIs remain first-line for anxiety disorders, but many patients need alternatives due to inadequate response, intolerable side effects, or comorbid...
Clinical Practice
Managing Psychiatric Medication Side Effects: A PMHNP Clinical Decision Guide
Side effect management is where PMHNPs earn patient trust and medication adherence. This clinical decision guide covers evidence-based strategies for the...
Clinical Practice
Psychiatric Medication Interactions Every PMHNP Should Have Memorized
Dangerous psychiatric medication interactions cause thousands of preventable adverse events annually. This reference guide covers the critical...
Clinical Practice
Ketamine and Esketamine in Psychiatric Practice: What PMHNPs Need to Know in 2026
Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026.
Clinical Practice
Buprenorphine Prescribing for PMHNPs: What Changed After the X-Waiver Elimination
With the X-waiver eliminated, all DEA-licensed PMHNPs can now prescribe buprenorphine for opioid use disorder without special certification.
Clinical Practice
Lithium Prescribing in 2026: Updated Renal Safety Guidelines for PMHNPs
New 2026 consensus guidelines revise lithium renal monitoring protocols, recommending eGFR checks every 3 months for the first year and introducing...
Clinical Practice
Clozapine Monitoring Updates 2026: REMS Changes Every PMHNP Must Know
The FDA has streamlined clozapine REMS requirements for 2026, reducing ANC monitoring frequency for established patients while maintaining safety...